Non-surgical and localized delivery of placental growth factor compositions - Patents.com
Bioerodible masses from micronized placental tissue, combined with thixotropic or phase change agents, address the limitations of invasive delivery methods by providing sustained release and prolonged therapeutic effects for placental growth factors.
Patent Information
- Application Number
- JP2022030767
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2015-09-03
- Filing Date
- 2022-03-01
- Publication Date
- 2024-11-27
- Estimated Expiration
- 2036-09-06
AI Technical Summary
Existing methods for delivering placental growth factors are limited by the size and retention time of micronized particles, requiring invasive procedures and constrained by the width of injection needles, leading to suboptimal treatment duration and effectiveness.
The use of bioerodible or biodegradable masses formed from micronized placental tissue, combined with thixotropic or phase change agents, to create a localized, sustained release of growth factors at the treatment site, ensuring prolonged therapeutic effects.
This approach allows for prolonged retention and sustained release of growth factors, enhancing treatment efficacy by maintaining therapeutic levels over extended periods without invasive procedures.
Abstract
Citation Information
Patent Citations
Composition of micronized placental tissue and method for preparing and using the same
JP2014505111A
JPP7391508B
Micronized placental tissue compositions and methods of making and using the same
US20140050788A1
Method for inducing angiogenesis
WO2015109329A1
